Sign in

CIK 0001625297

  • Large accelerated filer

Supernus, Inc.

Sign in to watch
Tickers
INDV SUPN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
412520873
Phone
+1 804-379-1090
Business address
9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
Former names
Indivior Pharmaceuticals, Inc., INDIVIOR PLC

Securities

  • INDV Common stock Nasdaq
  • SUPN Common Stock Nasdaq
  1. 4 Grant or award Chief Financial Officer acquired 37,358 shares (grant or award)
  2. 4 Grant or award Chief Legal Officer acquired 26,897 shares (grant or award)
  3. 4 Grant or award Chief Scientific Officer acquired 33,622 shares (grant or award)
  4. 4 Grant or award Chief Commercial Officer acquired 31,380 shares (grant or award)
  5. 4 Grant or award Chief Executive Officer acquired 79,976 shares (grant or award)
  6. 4 Grant or award Director acquired 3,722 shares (grant or award)
  7. 4 Grant or award Director acquired 5,955 shares (grant or award)
  8. 4 Grant or award Director acquired 3,722 shares (grant or award)
  9. 4 Grant or award Director acquired 3,722 shares (grant or award)
  10. 4 Grant or award Director acquired 3,722 shares (grant or award)
  11. 4 Grant or award Director acquired 3,722 shares (grant or award)
  12. 4 Grant or award Director acquired 3,722 shares (grant or award)
  13. 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
  14. 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
  15. 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
  16. 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
  17. 4 Open-market buy Director bought 1,771 shares at $35.39 ($62,680)
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 3 of 4 · 70 filings